C12N 9/0093
Acting on ch or ch2 groups
Official title: {acting on CH or CH2 groups (1.17)}
C12N9/0093 (Acting on ch or ch2 groups) appears on 89 US grants and 122 published applications in this corpus.
Search patents in C12N- Granted patents
- 89
- Published applications
- 122
- Assignees
- 101
- Inventors
- 378
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 3 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 7 | 0 |
| 1999 | 6 | 0 |
| 2000 | 3 | 0 |
| 2001 | 5 | 3 |
| 2002 | 3 | 2 |
| 2003 | 5 | 3 |
| 2004 | 2 | 3 |
| 2005 | 0 | 5 |
| 2006 | 1 | 4 |
| 2007 | 3 | 3 |
| 2008 | 2 | 2 |
| 2009 | 0 | 1 |
| 2010 | 3 | 3 |
| 2011 | 3 | 3 |
| 2012 | 1 | 4 |
| 2013 | 1 | 1 |
| 2014 | 3 | 2 |
| 2015 | 2 | 4 |
| 2016 | 1 | 4 |
| 2017 | 3 | 6 |
| 2018 | 5 | 6 |
| 2019 | 1 | 5 |
| 2020 | 4 | 5 |
| 2021 | 4 | 4 |
| 2022 | 2 | 10 |
| 2023 | 1 | 7 |
| 2024 | 7 | 11 |
| 2025 | 3 | 10 |
| 2026 | 4 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Recombinant host cells with improved production of tetraketide derivatives22 Sep 2026US 12,742,189 B2Iptector Assets Aps
- Process for producing formate using oxygen-tolerant enzymes16 Jun 2026US 12,655,454 B2Gwangju Institute of Science and Technology
- Modified polypeptide of meso-diaminopimelate dehydrogenase and polynucleotide encoding the modified polypeptide17 Feb 2026US 12,553,056 B2Cj Cheiljedang Corporation
- Gene duplications for crabtree-warburg-like aerobic xylose fermentation17 Feb 2026US 12,553,066 B2Wisconsin Alumni Research Foundation
- Variant dihydrodipicolinate reductase polypeptide and method of producing L-threonine using the same16 Dec 2025US 12,497,626 B2Cj Cheiljedang Corporation
- Method for producing d-talitol, d-tagatose, and d-psicose8 Oct 2026US 2026/0308649 A1Annikki GmbH
- Anaerobic co-production of essential amino acids, alcohols and lipids from molasses, hydrolysed starch and lignocellulose10 Sep 2026US 2026/0265796 A1SNL BioSolution Aps
- Method for producing allitol3 Sep 2026US 2026/0258453 A1Annikki GmbH
- Recombinant host cells with improved production of tetraketide derivatives27 Aug 2026US 2026/0250728 A1Iptector Assets Aps
- Enzyme co-immobilization for biosynthesis20 Aug 2026US 2026/0242427 A1The Chinese University of Hong Kong
Most cited
By later US patents
- PEG-urate oxidase conjugates and use thereof100US 6,576,235 B1Duke University · 2003
- Human ribonucleotide reductase M2 subunit89US 7,157,570 B22007
- Chalcone synthase dihydroflavonol 4-reductase and leucoanthocyanidine reductase from clover, medic ryegrass or fescue85US 8,093,451 B2AgResearch Limited · 2012
- Antitumor antisense sequences directed against ribonucleotide reductase33US 5,998,383 A1999
- Genetically engineered cell line for detecting infectious herpes simplex virus and method therefore29US 5,418,132 AWashington University · 1995